Exosome Diagnostics, founded in 2008, is a global leader in the rapidly growing non-invasive liquid biopsy market. The company has built a product pipeline and service platforms around its unique ...

ExosomeDx is a pioneer in exosome ... biopsy market; the company’s ExoDx Prostate test, for example, is the first and only commercially available test that uses an exosome-based liquid biomarker.

Another limitation was the lack of an established microRNA ... exosome-based liquid biopsy accurately detected 97% of stage 1-2 pancreatic cancers when combined with the biomarker CA 19-9 ...

Eli Lilly & Company has entered into a collaboration agreement with Exosome Diagnostics for blood-based biomarker discovery and validation using Exosome Diagnostics' proprietary EXO50 nucleic acid ...

Particularly microRNAs have emerged as informative biomarkers of cell status and function ... to cluster nicely with Illumina ® and Ion Torrent ® sequencing results. microRNA detection in very dilute ...

The study isolated exosomes from more than 500 blood samples through the use of INOVIQ’s EXO-NET – a tool used for biomarker discovery and diagnostic development – on a high-throughput ...